CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- 4 Open-market buy President and COO bought 12,512 shares at $0.79 ($9,884)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and Director bought 15,000 shares at $0.77 ($11,550)
- 4 Open-market buy Director bought 100,000 shares at an average $0.77 ($76,700)
- 4 Open-market buy Chief Financial Officer bought 45,000 shares at $0.71 ($32,076)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market buy Director bought 143,075 shares at $0.70 ($100,024)
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
Page 7 of 42 · 832 filings